Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Treating Myofascial Pain Syndrome in Adults Aged 18 to 65

What this Trial Is About

Researchers are investigating the effectiveness of a new ultrasound-guided treatment called the Serratus Posterior Superior Intercostal Plane Block SPSIPB for Myofascial Pain Syndrome MAS, a condition causing muscle pain and tension due to trigger points. MAS often affects young people and desk workers. This observational study compares SPSIPB with the traditional trigger point injection method to understand which provides better relief. The study was conducted at the Algology Department of Kanuni Sultan Sleyman Training and Research Hospital between March 2023 and March 2024. The SPSIPB targets the serratus posterior superior muscle located under the rhomboid muscles, using ultrasound guidance to deliver the block from a single injection point. The traditional treatment involves trigger point injections to relax tense muscle bands. Both treatments are applied once to the neck and back region. The study collects data retrospectively from patients aged 18 to 65 who received either SPSIPB or trigger point injections during this period. Participants records are reviewed for age, gender, pain levels measured by Visual Analog Scale VAS, neck disability scores, and muscle sensitivity before treatment and at one and three months after the procedure. The main outcome is the timing and onset of pain relief measured over four months. This helps understand how each treatment affects pain and function in MAS patients. The study monitors patient safety and treatment effects through these assessments.

Effectiveness of Serratus Posterior Superior Intercostal Plane Block Applied With Ultrasonography in Myofascial Pain Syndrome